Spyre Therapeutics (SYRE) EV to EBITDA (2016 - 2026)

Spyre Therapeutics (SYRE) EV to EBITDA (2016 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	EV to EBITDA
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-874.56
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-566,202.17
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-197,878.48
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-58,863.88
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-168,912.54
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-304,774.20
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	22.61
9	Abivax	90.15 Bn	90.15 Bn	-	-304.27
10	Spyre Therapeutics	6.35 Bn	6.35 Bn	-	-31.49

Download Data